- Founded
- 1989
- Employees
- 15,000
- Total Funding
- $22M
Founded by August Krogh, Marie Krogh in 1989.
About Novo Nordisk
Novo Nordisk is a Danish multinational pharmaceutical company specializing in the development and manufacture of medications for diabetes, obesity, cardiovascular disease, and rare blood and endocrine disorders. The company is the worlds largest producer of insulin and markets its products in 168 countries, with its GLP-1 receptor agonist drugs becoming among the most widely used treatments for diabetes and obesity. Novo Nordisk is headquartered in Bagsvaerd, Denmark.
Leadership at Novo Nordisk
The team at the top of the org chart.
Anonymous
President & CEO
4,191 reports
Alan Moses
Senior Vice President And Global Chief Medical Officer
977 reports
Martin Holst Lange
Executive Vice President of R&D & Chief Scientific Officer
674 reports
Doug Langa
Executive Vice President, North America Operations
463 reports
Tania Sabroe
Executive Vice President, People, Organisation & Corporate Affairs
427 reports
Jamey Millar
Executive Vice President, US Operations
396 reports
Yiannis Mallis
Senior Vice President Portfolio Strategy & Access
357 reports
Karsten Munk Knudsen
Executive Vice President, Chief Financial Officer
208 reports
Kasper Bødker Mejlvang
Executive Vice President, CMC & Product Supply
167 reports
Board
Mette Bøjer Jensen
Member of the Board
Stephan Engels
Director
Lars Rebien Sørensen
Chair
Britt Meelby Jensen
Director
Cees De Jong
Vice Chairman
Liselotte Hyveled
Member of the Board
Open Jobs at Novo Nordisk (430)
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo
- Novo Nordisk · 1mo